Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (Review)

International Journal of Oncology

Volumn 21, Issue 6, 2002, Pages 1285-1292

  Rose, David P ^a   Gilhooly, Elaine M ^a   Nixon, Daniel W ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEPTIN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA;

BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; ENZYME ACTIVITY; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; INSULIN BLOOD LEVEL; NONHUMAN; OBESITY; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR DIAGNOSIS; ANIMAL; BREAST TUMOR; FEMALE; METABOLISM; PHYSIOLOGY;

ANIMALS; AROMATASE; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN; LEPTIN; NF-KAPPA B; OBESITY; SIGNAL TRANSDUCTION;

EID: 0000034343     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.21.6.1285     Document Type: Review

References (100)

1. De Waard F, Baanders-van Halewijn EA and Huizinga J: The bimodal age distribution of patients with mammary carcinoma. Cancer 17: 141-151, 1964.
2. La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D and Decarli A: Body mass index and post-menopausal breast cancer: An age-specific analysis. Br J Cancer 75: 441-444, 1997.
3. Swanson CA, Coates RJ, Schoenberg JB, et al. Body size and breast cancer risk among women under age 45 years. Am J Epidemiol 143: 698-706, 1996.
4. Chlebowski RT, Aiello E and McTiernan A: Weight loss in breast cancer patient management. J Clin Oncol 20: 1128-1143, 2002.
5. Rose DP: Diet, hormones, and cancer. Annu Rev Public Health 14: 1-17, 1993.
6. Halaas JL, Gajiwala KS, Maffei M, et al. Comment: weightreducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
7. MacDougald OA, Hwang CS, Fan H and Lane MD: Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sei USA 92: 9034-9037, 1995.
8. Bouloumie A, Marumo T, Lafontan M and Busse R: Leptin induces oxidative stress in human endothelial cells. FASEB J 13: 1231-1238, 1999.
9. Biswas DK, Cruz AP, Gansberger E and Pardee AB: Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sei USA 97: 8542-8547, 2000.
10. Huang S, Pettaway CA, Uehara H, Bucana CD and Fidler IJ: Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20: 4188-4197, 2001.
11. Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ and Meakin JW: Body weight and prognosis in breast cancer. J Natl Cancer Inst 67: 785-789, 1981.
12. Verreault R, Brisson J, Deschenes L and Naud F: Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 129: 260-268, 1989.
13. Tormey DC, Gray R, Gilchrist K, et al. Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5- fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial. Cancer 65: 200-206, 1990.
14. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20: 42-51, 2002.
15. Huang L and Li C: Leptin: A multifunctional hormone. Cell Res 10: 81-92, 2000.
16. Konukoglu D, Serin O and Ercan M: Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy. Maturitas 36: 203-207, 2000.
17. Der Merwe MT, Panz VR, Crowther NJ, et al. Free fatty acids and insulin levels - relationship to leptin levels and body composition in various patient groups from South Africa. Int J Obes Relat Metab Disord 23: 909-917, 1999.
18. Thomas T, Burguera B, Melton LJ III, Atkinson EJ, O'Fallon WM, Riggs BL and Khosla S: Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 49: 1278-1284, 2000.
19. Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC and Hu FB: Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 73: 61-67, 2001.
20. Askari H, Liu J and Dagogo-Jack S: Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin. Int J Obes Relat Metab Disord 24: 1254-1259, 2000.
21. Mantzoros CS: Role of leptin in reproduction. Ann NY Acad Sci 900: 174-183, 2000.
22. Caprio M, Fabbrini E, Isidori AM, Aversa A and Fabbri A: Leptin in reproduction. Trends Endocrinol Metab 12: 65-72, 2001.
23. Magoffin DA, Weitsman SR, Aagarwal SK and Jakimiuk AJ: Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. Ginekol Pol 70: 1-7, 1999.
24. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K and Harkonen PL: Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149: 29-40, 1999.
25. Liekens S, De Clercq E and Neyts J: Angiogenesis: regulators and clinical applications. Biochem Pharmacol 61: 253-270, 2001.
26. Smith SK: Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 12: 147-151, 2001.
27. Spranger J and Pfeiffer AF: New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 109: S438-S450, 2001.
28. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
29. Rose DP and Connolly JM: Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 37: 119-127, 2000.
30. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271: 603-606, 1996.
31. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 281: 1683-1686, 1998.
32. Bouloumie A, Drexler HC, Lafontan M and Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83: 1059-1066, 1998.
33. Park HY, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33: 95-102, 2001.
34. Kume K, Satomura K, Nishisho S, Kitaoka E, Yamanouchi K, Tobiume S and Nagayama M: Potential role of leptin in endochondral ossification. J Histochem Cytochem 50: 159-169, 2002.
35. Artwohl M, Roden M, Holzenbein T, Freudenthaler A, Waldhausl W and Baumgartner-Parzer SM: Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 26: 577-580, 2002.
36. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J and Cao Y: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sei USA 98: 6390-6395, 2001.
37. Ribatti D, Nico B, Belloni AS, Vacca A, Roneali L and Nussdorfer GG: Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med 8: 265-268, 2001.
38. Brunetti L, Orlando G, Michelotto B, Ragazzoni E and Vacca M: Leptin stimulates prostaglandin E2 and F2alpha, but not nitric oxide production in neonatal rat hypothalamus. Eur J Pharmacol 369: 299-304, 1999.
39. Fain JN, Leffler CW and Bahouth SW: Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture. J Lipid Res 41: 1689-1694, 2000.
40. Fain JN, Leffler CW, Cowan GS Jr, Buffington C, Pouncey L and Bahouth SW: Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans. Metabolism 50: 921-928, 2001.
41. Wang A, Nomura M, Patan S and Ware JA: Inhibition of protein kinase Calpha prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo. Circ Res 90: 609-616, 2002.
42. Takekoshi K, Ishii K, Nanmoku T, Shibuya S, Kawakami Y, Isobe K and Nakai T: Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology 142: 4861-4871, 2001.
43. Kohn EC and Liotta LA: Invasion and metastasis: new approaches to an old problem. Oncology 7: 47-52, 1993.
44. Singh J, Hamid R and Reddy BS: Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57: 3465-3470, 1997.
45. Rose DP: Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66 (Suppl.): 1513S-1522S, 1997.
46. Rose DP and Connolly JM: Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 83: 217-244, 1999.
47. Rose DP and Connolly JM: Dietary fat and breast cancer metastasis by human tumor xenografts. Breast Cancer Res Treat 46: 225-237, 1997.
48. Takahashi Y and Ide T: Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br J Nutr 84: 175-184, 2000.
49. Raclot T, Groscolas R, Langin D and Ferre P: Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38: 1963-1972, 1997.
50. Hun CS, Hasegawa K, Kawabata T, Kato M, Shimokawa T and Kagawa Y: Increased uncoupling protein2 mRNA in white adipose tissue, and decrease in leptin, visceral fat, blood glucose, and cholesterol in KK-Ay mice fed with eicosapentaenoic and docosahexaenoic acids in addition to linolenic acid. Biochem Biophys Res Commun 259: 85-90, 1999.
51. Wang H, Storlien LH and Huang XF: Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 282: E1352-E1359, 2002.
52. Oda A, Taniguchi T and Yokoyama M: Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sei 47: 141-150, 2001.
53. Hardwick JC, van Den Brink GR, Offerhaus GJ, van Deventer SJ and Peppelenbosch MP: Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121: 79-90, 2001.
54. Liu Z, Uesaka T, Watanabe H and Kato N: High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 9: 1009-1014, 2001.
55. Laud K, Gourdou I, Pessemesse L, Peyrat JP and Djiane J: Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188: 219-226, 2002.
56. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R and Giudicelli Y: Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293: 622-628, 2002.
57. Chilliard Y, Bonnet M, Delavaud C, Faulconnier Y, Leroux C, Djiane J and Bocquier F: Leptin in ruminants. Gene expression in adipose tissue and mammary gland, and regulation of plasma concentration. Domest Anim Endocrinol 21: 271-295, 2001.
58. O'Brien SN, Welter BH and Price TM: Presence of leptin in breast cell lines and breast tumors. Biochem Biophys Res Commun 259: 695-698, 1999.
59. Gasparini G, Bevilacqua P, Boracchi P, et al: Prognostic value of p53 expression in early-stage breast carcinoma compared with tumor angiogenesis, epidermal growth factor receptor, c-erb B-2, cathepsin D, DNA ploidy, parameters of cell kinetics and conventional features. Int J Oncol 4: 155-162, 1994.
60. Toi M, Inada K, Suzuki H and Tominaga T: Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204, 1995.
61. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR and Hellman S: Angiogenesis as a predictor of long-Term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88: 1764-1769, 1996.
62. Engels K, Fox SB and Harris AL: Angiogenesis as a biologic and prognostic indicator in human breast carcinoma. EXS 79: 113-156, 1997.
63. Gasparini G: Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 5 (Suppl.1): 37-44, 2000.
64. Linderholm BK, Lindahl T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R and Bergh J: The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res 61: 2256-2260, 2001.
65. Hursting SD, Perkins SN, Phang JM and Barrett JC: Diet and cancer prevention studies in p53-deficient mice. J Nutri 131: 3092S-3094S, 2001.
66. Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin North Am 10:383-392, 2001.
67. Jones JL, Glynn P and Walker RA: Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189: 151-158, 1999.
68. Hanemaaijer R, Verheijen JH, Maguire TM, et al: Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer 86: 204-207, 2000.
69. Castellucci M, De Matteis R, Meisser A, et al: Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod 6: 951-958, 2000.
70. Attoub S, Noe V, Pirola L, et al: Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3- kinase-, rho-, and rac-dependent signaling pathways. FASEB J 14:2329-2338, 2000.
71. Rose DP and Hatala MA: Dietary fatty acids and breast cancer invasion and metastasis. Nutr Cancer 21: 103-111, 1994.
72. Gilhooly EM and Rose DP: The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol 15: 267-270, 1999.
73. Kundu N, Yang Q, Dorsey R and Fulton AM: Increased cyclooxygenase- 2 (cox-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer 93: 681-686, 2001.
74. Morsc-Gaudio M, Connolly JM and Rose DP: Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int J Oncol 12: 1349-1354, 1998.
75. Johnson MD, Tom JA, Lippman ME and Dickson RB: Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp Cell Res 247: 105-113, 1999.
76. Uchida Y, Ohba K, Ogawa A, Wada K, Yoshioka T and Muraki T: Protein kinase C mediates tumor necrosis factoralpha- induced inhibition of obese gene expression and leptin secretion in brown adipocytes. Nauyn Schmiedebergs Arch Pharmacol 360: 691-698, 1999.
77. Honn KV, Tang DG and Crissman JD: Platelets and cancer metastasis: A causal relationship? Cancer Metastasis Rev 11: 325-351, 1992.
78. Steinert BW, Tang DG, Grossi IM, Umbarger LA and Honn KV: Studies on the role of platelet eicosanoid metabolism and integrin alpha lib beta 3 in tumor-cell-induced platelet aggregation. Int J Cancer 54: 92-101, 1993.
79. Vezza R, Roberti R, Nenci GG and Gresele P: Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. Blood 82: 2704-2713, 1993.
80. Nakata M, Yada T, Soejima N and Maruyama I: Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48: 426-429, 1999.
81. Serrano Rios M: Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 28 (Suppl.2): 14-17, 1998.
82. Pinkus R, Weiner LM and Daniel V: Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-Transferase gene expression. J Biol Chem 271: 13422-13429, 1996.
83. Mercurio F and Manning AM: NF-kappaB as a primary regulator of the stress response. Oncogene 18: 6163-6171, 1999.
84. Bours V, Bentires-Alj M, Hellin AC, et al: Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol 60: 1085-1089, 2000.
85. Varela LM, Stangle-Castor NC, Shoemaker SF, Shea-Eaton WK and Ip MM: TNFa induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J Cell Physiol 188: 120-131, 2001.
86. Yang JQ, Zhao W, Duan H, Robbins ME, Buettner GR, Oberley LW and Domann FE: V-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. Free Radie Biol Med 31: 520-529, 2001.
87. Lelkes PI, Hahn KL, Sukovich DA, Karmiol S and Schmidt DH: On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 454: 295-310, 1998.
88. Tessitore L, Vizio B, Jenkins O, et al: Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5: 421-426, 2000.
89. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N and Trichopoulos D: Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11:383-388, 2000.
90. Hankinson SE, Willett WC, Colditz GA, et al: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396, 1998.
91. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, Shore RE and Zeleniuch-Jacquotte A: Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88: 828-832, 2000.
92. Bruning PF, van Doom J, Bonfrer JM, van Noord PA, Korse CM, Linders TC and Hart AA: Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62: 266-270, 1995.
93. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ and Clinton SK: Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 91: 512-523, 1999.
94. Uckaya G, Ozata M, Bayraktar Z, Erten V, Bingol N and Ozdemir IC: Is leptin associated with diabetic retinopathy? Diabetes Care 23: 371-376, 2000.
95. Miller WR, Mullen P, Sourdaine P, Watson C, Dixon JM and Telford J: Regulation of aromatase activity within the breast. J Steroid Biochem Mol Biol 61: 193-202, 1997.
96. Marttunen MB, Andersson S, Hietanen P, et al: Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients. Maturitas 35: 175-179, 2000.
97. The ATAC Trialists' Group: Arimidex tamoxifen alone or in combination: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359: 2131-2139, 2002.
98. Reddy BS and Rao CV: Colon cancer: A role for cyclooxygenase- 2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging 16: 329-334, 2000.
99. Connolly JM, Liu X-H and Rose DP: Dietary linoleic acidstimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr Cancer 25: 231-240, 1996.
100. Liu XH and Rose DP: Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56: 5125-5127, 1996.